Literature DB >> 12530461

Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration.

Jost B Jonas, Ingrid Kreissig, Robert Degenring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12530461     DOI： 10.1007/s00417-002-0547-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  10 in total

1.  Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.

Authors:  A P Ciardella; J Klancnik; W Schiff; G Barile; K Langton; S Chang
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

2.  Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Authors:  D Wong; I Campbell; C Groenwald; E Lancaster
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

3.  Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; R F Degenring
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

4.  Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Authors:  J B Jonas; I Kreissig; P Hugger; G Sauder; S Panda-Jonas; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

5.  Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

Authors:  J B Jonas; I Akkoyun; I Kreissig; R F Degenring
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

6.  Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles.

Authors:  Viral Tamboli; Gyan P Mishra; Ashim K Mitra
Journal:  Colloid Polym Sci       Date:  2013-05-01       Impact factor: 1.931

7.  RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.

Authors:  Rajendra S Kadam; Puneet Tyagi; Henry F Edelhauser; Uday B Kompella
Journal:  Int J Pharm       Date:  2012-05-23       Impact factor: 5.875

8.  Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone.

Authors:  T Kube; M Sutter; R Trittler; N Feltgen; L L Hansen; H T Agostini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-05-20       Impact factor: 3.117

9.  Photodynamic therapy combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.

Authors:  Xiaobing Yu; Hong Dai; Yingyi Lu; Li Long
Journal:  Front Med China       Date:  2007-10

Review 10.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.